New Double Chin Treatment Receives FDA Approval


The U.S. Food and Drug Administration announced approval for an exciting new double chin treatment yesterday. Kybella, a version of a naturally occurring compound called deoxycholic acid, helps the body absorb fats and is designed specifically to reduce double chins.

“Treatment with Kybella should only be provided by a licensed health care professional, and patients should fully understand the risks associated with use of the drug before considering treatment,” FDA’s Dr. Amy Egan said in a statement.

“It’s important to remember that Kybella is only approved for the treatment of fat occurring below the chin, and it is not know if Kybella is safe or effective for treatment outside of this area.”

Kythera, the California-based manufacturer of Kybella, hopes to use the new drug to breakthrough into the medical aesthetics industry.

Patients may receive up to 50 injections in one treatment depending on the physician’s recommendation. If needed, patients can come back for 6 full treatments scheduled at least one month apart. There is some pain at the injection site and study patients reported bruising, pain, numbness, ands swelling, which are not uncommon with other injectables. A few study patients reported more concerning side-effects, such as trouble swallowing, but such problems didn’t persist.

Dr. Michael Edwards, president of the Society for Aesthetic Plastic surgery, cautions that it’s not for everyone. “My biggest concern is once it is approved, people will start to use it for other areas of the face or for larger volumes (of fat) in other areas,”

Currently, patients are able to achieve great results with submental liposuction, the removal of fat under the chin. Having an additional option to offer patients that is less invasive certainly sounds promising. More information will be coming soon on the use of Kybella at Utah Facial Plastics.



Tagged with: , , , ,

Posted in: Injectables


  1. […] have been anxiously awaiting the arrival of Kybella, which received FDA approval for double chin reduction in April this year. The company predicts […]

    Pingback by Top Plastic Surgery Trends | Utah Facial Plastics : Utah Facial Plastics on June 15, 2015 at 7:44 pm

  2. Hello, I was wondering if you perform Kybella yet or if its even been released yet? I’m interested

    Comment by Jesse Marin on June 24, 2015 at 2:03 am

  3. It’s been approved by the FDA but the company is still working out pricing and getting their trainers ready. They predict we’ll be able to offer Kybella by the end of the year. I have a list of patients interested as soon as we get it that I could add you to and keep you posted?

    Comment by Jenny Yergensen on June 24, 2015 at 2:51 pm

  4. I’d love to be put on my list, can I be added with my email?

    Comment by R on August 25, 2015 at 2:18 am

  5. I’ve added you to the list! Thanks!!

    Comment by Jenny Yergensen on August 25, 2015 at 4:08 pm

  6. Would I be able to to be added to that list as well?
    Thanks so much!

    Comment by Haley on April 25, 2016 at 2:50 pm

  7. I have a moderate double chin, though mine is more genetic than anything I am afraid. I’m 27, athletic and weight 180, but my chin is always something I’ve been shy about.

    I am wondering if this treatment may still work for me even though I am not really overweight?

    Comment by James M on July 31, 2015 at 9:24 pm

  8. […] this past week at the American Society for Dermatologic Surgery annual meeting that two phase 3 Kybella trials had reduction in submental fat and men were satisfied with the […]

    Pingback by Kybella Effective & Satisfactory in Trials with Men on October 18, 2015 at 9:23 pm

  9. […] known as ATX-101, Kybella is a new non-surgical injectable specifically designed to treat moderate to severe fat on the upper […]

    Pingback by What Is Kybella? on October 26, 2015 at 4:51 am

The comments are closed.

Contact Us

Call (801) 776-2220 with Questions or to Schedule an Appointment Today!

  • This field is for validation purposes and should be left unchanged.

Call Now Button